Hubungan antara Jumlah Monosit Absolut, Tumor Associated Macrophage dan Tumor Infiltrating Lymphocytes terhadap Event Free Survival 2 Tahun pada Diffuse Large B-Cell Lymphoma yang mendapatkan terapi RCHOP = Correlation between Absolute Monocyte Count, Tumor-Associated Macrophage and Tumor Infiltrating Lymphocytes to Event Free Survival 2 years in Diffuse Large B-Cell Lymphoma receiving RCHOP therapy

Ekspresi protein programmed cell death ligand-1 (PD-L1) dan programmed cell death-1 (PD-1) pada diffuse large B-cell lymphoma (DLBCL) subtipe germinal center B-cell-like (GCB) dan non-germinal center B-cell-like (non-GCB) = Expression of programmed cell death ligand-1 (PD-L1) and programmed cell death-1 (PD-1) protein in germinal center B-cell-like (GCB) dan non-germinal center B-cell-like (non-GCB) subtypes of diffuse large B-cell lymphoma (DLBCL).

Ekspresi CTLA-4 pada Diffuse Large B-Cell Lymphoma Subtipe Germinal Center B-cell-like dan Non-Germinal Center B-cell-like Sebagai Penanda Prognostik Dan Potensi Imunoterapi = Expression of CTLA-4 in Diffuse Large B-Cell Lymphoma Germinal Center B-cell-like and Non-Germinal Center B-cell-like Subtypes as Prognostic and Potential Immunotherapy Markers

Hubungan Ekspresi Protein CD10, BCL6, MUM1, dan Ki67 secara Kuantitatif dengan Event-Free Survival 24 Bulan Pasien Diffuse Large B-Cell Lymphoma yang Mendapatkan Terapi R-CHOP = Correlation Between Quantitative Protein Expression of CD10, BCL6, MUM1, and Ki67 with Event-Free Survival at 24 Months in DLBCL Receiving R-CHOP Therapy

Ekspresi myelin and lymphocyte (MAL) pada Primary mediastinal large b-cell lymphoma (PMBCL) dan limfoma hodgkin klasik mediastinum = Myelin and lymphocyte (MAL) expression in primary mediastinal large b-cell lymphoma (PMBCL) and mediastinal classical hodgkin lymphoma.